Table 2

Tracing the spread of the TP53 p.E294fs*51 (c.880delG) mutant clone over time in patient 1

AFB
date
MonthBiopsy siteDiagnosisAFB statusTP53 statusLoH/RoH (D17S 1881)
10/2000M38LUL stumpCIS+MutantLoH
LLL orifice (control)NADWildtypeRoH
LLL (control)NADWildtypeRoH
*MC (control)NADWildtypeRoH/RoH
RUL (control)NADWildtypeRoH
RLL (control)NADWildtypeRoH
03/2001M43LUL stumpSD+MutantLoH
07/2001M47LUL stumpCIS+MutantLoH
12/2001M51LLL (control)NADWildtypeRoH
01/2003M64Left main bronchusSD+MutantN/A
07/2003M70LLL (control)NADWildtypeRoH
†LLL orificeSD+MutantLoH /LoH
Proximal left main bronchusSD+MutantLoH
Left main bronchusCIS+MutantN/A
11/2003M74LLL (control)NADWildtypeN/A
Proximal left main bronchusCIS+MutantN/A
05/2004M80LLL (control)NADWildtypeN/A
09/2004M84LLL (control)NADWildtypeN/A
04/2006M104MCCIS+MutantN/A
MC (control)NADWildtypeN/A
08/2006M108Lower anterior tracheaCIS+MutantLoH
01/2007M113Lower lateral tracheaCIS+MutantLoH
04/2007M116Lower tracheaCIS+MutantN/A
03/2008M127RMB (control)NADWildtypeN/A
RMBMoD+MutantN/A
Lower trachea (control)NADWildtypeRoH
08/2008M132MC/stumpCIS+MutantN/A
Proximal RMB medial wallCIS+MutantLoH
Proximal RMB medial wallSD+MutantN/A
01/2009M137RMBCIS+MutantN/A
LMB stumpCIS+MutantLoH
07/2009M143Lateral wall of orifice to RMBCIS+MutantLoH
Posterior wall proximal RMBCIS+MutantLoH
Left pneumonectomy stumpCIS+MutantLoH
11/2010M159RMBMiDWildtypeRoH
RMBMetaplasiaWildtypeRoH
MCCIS+MutantLoH
MCMiDWildtypeRoH
MC (control)NADWildtypeRoH
RML (control)NADWildtypeRoH
05/2011M165RMLCIS+MutantN/A
03/2012M175RMLCIS+MutantN/A
RLLCIS+MutantN/A
08/2012M180Posterior wall of RMBSqCC+MutantN/A
  • Month refers to post-lobectomy.

  • *At M38, two distinct areas of the MC were biopsied, providing two AFB and histology normal samples.

  • †At M70, two distinct AFB detected and histology-confirmed SD samples from the LLL orifice were analysed and found to carry the c.880delG. In total, 46 samples from 19 spatially distinct areas were analysed over a period of 12 years (M38–M180).

  • AFB, auto-fluorescence bronchoscopy; CIS, carcinoma in situ; LLL, left lower lobe; LMB, left main bronchus; LoH, loss of heterozygosity; LUL, left upper lobe; MiD, mild dysplasia; MoD, moderate dysplasia; N/A, not analysed due to insufficient DNA lysate; NAD, no abnormality detected; RLL, right lower lobe; RMB, right main bronchus; RML, right middle lobe; RoH, retention of heterozygosity; RUL, right upper lobe; SD, severe dysplasia.